MedTrace Logo

Prolongation of Contact Lens Comfortable Wear Duration by CLM2 Topical Gel

NCT03994406 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2023-03-24

No results posted yet for this study

Summary

This study compares contact lens comfortable wear duration, and signs and symptoms of contact lens discomfort, test versus control.

Conditions

  • Contact Lens Discomfort
  • Contact Lens-induced Corneal Disorder
  • Contact Lens Acute Red Eye
  • Contact Lens-induced Corneal Fluorescein Staining

Interventions

DRUG

CLM2 topical gel

Active topical gel for forehead dermal application

DRUG

Placebo topical gel

Placebo topical gel for forehead dermal application

Sponsors & Collaborators

  • Glia, LLC

    lead INDUSTRY

Principal Investigators

  • Meng C. Lin, OD,PhD,FAAO · University of California, Berkeley

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-27
Primary Completion
2019-08-30
Completion
2019-10-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03994406 on ClinicalTrials.gov